Angelman Syndrome (AS) Biomarker Study

Clinical trial NCT04103333 · COMPLETED

Trial details

NCT number: NCT04103333
Sponsor: Biogen
Status: COMPLETED
Phase: Early Phase 1
Study type: INTERVENTIONAL

Angelman Syndrome Chromosome 15q Duplication (dup15q) Syndrome

Start date: 2019-12-18
Primary completion: 2022-01-02
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.